E
Calliditas Therapeutics AB (publ) CALT
NASDAQ
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2024 03/31/2024 12/31/2023 09/30/2023 06/30/2023
Net Income -62.86% -28.37% -2.37% 36.76% 57.28%
Total Depreciation and Amortization 29.45% 29.45% 29.45% 65.29% 65.29%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 2,262.33% 523.37% 4,372.85% 689.78% -62.46%
Change in Net Operating Assets 155.09% -226.19% -194.58% 309.22% 29.46%
Cash from Operations 16.72% -7.66% -22.32% 70.05% 57.16%
Capital Expenditure -412.88% -412.88% -412.88% 68.49% 68.49%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 76.57% 36.70% 70.26% -301.45% -98.81%
Cash from Investing -114.46% -168.32% -147.86% -22.08% 35.28%
Total Debt Issued 277.18% 95.81% 95.81% 7.96% -41.45%
Total Debt Repaid -6,384.63% -6,664.70% -7,561.08% -30.02% -35.90%
Issuance of Common Stock -99.96% -- -- -50.73% -91.88%
Repurchase of Common Stock -- -- -- 100.00% 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -2,009.83% -2,009.83% -2,008.16% 96.77% 98.29%
Cash from Financing -27.89% -62.83% -66.82% 0.10% -68.84%
Foreign Exchange rate Adjustments -112.56% -50.88% -173.61% -47.32% 142.18%
Miscellaneous Cash Flow Adjustments -200.00% -200.00% -150.00% 0.00% 0.00%
Net Change in Cash -901.79% -214.54% -202.72% 108.73% -95.15%
Weiss Ratings